Hytham Al‐Masri

530 total citations
14 papers, 396 citations indexed

About

Hytham Al‐Masri is a scholar working on Oncology, Pathology and Forensic Medicine and Molecular Biology. According to data from OpenAlex, Hytham Al‐Masri has authored 14 papers receiving a total of 396 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 4 papers in Pathology and Forensic Medicine and 3 papers in Molecular Biology. Recurrent topics in Hytham Al‐Masri's work include Cancer Immunotherapy and Biomarkers (4 papers), Lymphoma Diagnosis and Treatment (3 papers) and Radiomics and Machine Learning in Medical Imaging (2 papers). Hytham Al‐Masri is often cited by papers focused on Cancer Immunotherapy and Biomarkers (4 papers), Lymphoma Diagnosis and Treatment (3 papers) and Radiomics and Machine Learning in Medical Imaging (2 papers). Hytham Al‐Masri collaborates with scholars based in United States, United Kingdom and Spain. Hytham Al‐Masri's co-authors include Marietta Scott, Marlon C. Rebelatto, Craig Barker, Jill Walker, Paul Scorer, M. Ratcliffe, Alan Sharpe, Anita Midha, Serhan Alkan and Fulya Öz Puyan and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Clinical Cancer Research.

In The Last Decade

Hytham Al‐Masri

13 papers receiving 384 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hytham Al‐Masri United States	7	284	163	72	72	68	14	396
Ignazio Martellucci Italy	11	280 1.0×	110 0.7×	64 0.9×	67 0.9×	43 0.6×	16	356
Robert S. Brody United States	6	269 0.9×	176 1.1×	50 0.7×	42 0.6×	55 0.8×	11	453
Paloma Martín-Martorell Spain	11	279 1.0×	190 1.2×	82 1.1×	35 0.5×	37 0.5×	30	426
Chukwuemeka Ikpeazu United States	9	189 0.7×	144 0.9×	119 1.7×	44 0.6×	42 0.6×	23	356
Christopher Dakhil United States	8	263 0.9×	197 1.2×	43 0.6×	56 0.8×	37 0.5×	20	393
Guoqiang Wang China	9	455 1.6×	227 1.4×	89 1.2×	101 1.4×	62 0.9×	24	561
Seonggyu Byeon South Korea	11	283 1.0×	195 1.2×	79 1.1×	66 0.9×	39 0.6×	30	442
Alfonso Illiano Italy	7	317 1.1×	299 1.8×	75 1.0×	21 0.3×	43 0.6×	9	469
Yalun Li China	12	164 0.6×	163 1.0×	117 1.6×	82 1.1×	26 0.4×	39	412
Tuan S. Nguyen United States	10	150 0.5×	80 0.5×	133 1.8×	42 0.6×	50 0.7×	19	338

Countries citing papers authored by Hytham Al‐Masri

Since Specialization

Citations

This map shows the geographic impact of Hytham Al‐Masri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hytham Al‐Masri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hytham Al‐Masri more than expected).

Fields of papers citing papers by Hytham Al‐Masri

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hytham Al‐Masri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hytham Al‐Masri. The network helps show where Hytham Al‐Masri may publish in the future.

Co-authorship network of co-authors of Hytham Al‐Masri

This figure shows the co-authorship network connecting the top 25 collaborators of Hytham Al‐Masri. A scholar is included among the top collaborators of Hytham Al‐Masri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hytham Al‐Masri. Hytham Al‐Masri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Silva, Manuel A., Sylvie Hauert, Baruch Ovadia, et al.. (2024). Tumour assessment of ROR1 levels in various adult leukaemia and lymphoma types. PLoS ONE. 19(11). e0313026–e0313026.

Zhang, Mingjun, Ian Cushman, Henry Lik‐Yuen Chan, et al.. (2023). A Novel BCMA Immunohistochemistry Assay Reveals a Heterogenous and Dynamic BCMA Expression Profile in Multiple Myeloma. Modern Pathology. 36(4). 100050–100050. 2 indexed citations

Zając, M, Marietta Scott, M. Ratcliffe, et al.. (2019). Concordance among four commercially available, validated programmed cell death ligand-1 assays in urothelial carcinoma. Diagnostic Pathology. 14(1). 99–99. 38 indexed citations

Ratcliffe, M., Alan Sharpe, Anita Midha, et al.. (2017). Agreement between Programmed Cell Death Ligand-1 Diagnostic Assays across Multiple Protein Expression Cutoffs in Non–Small Cell Lung Cancer. Clinical Cancer Research. 23(14). 3585–3591. 237 indexed citations

Scott, Marietta, M. Ratcliffe, Alan Sharpe, et al.. (2017). Concordance of tumor and immune cell staining with Ventana SP142, Ventana SP263, Dako 28-8 and Dako 22C3 PD-L1 tests in NSCLC patient samples.. Journal of Clinical Oncology. 35(7_suppl). 7–7. 6 indexed citations

Scott, Marietta, M. Ratcliffe, Alan Sharpe, et al.. (2017). Concordance of tumor cell (TC) and immune cell (IC) staining with Ventana SP142, Ventana SP263, Dako 28-8 and Dako 22C3 PD-L1 IHC tests in NSCLC patient samples.. Journal of Clinical Oncology. 35(15_suppl). e14503–e14503. 5 indexed citations

Lubell, David, et al.. (2009). Syncope from dynamic left ventricular outflow tract obstruction simulating hypertrophic cardiomyopathy in a patient with primary AL-type amyloid heart disease.. PubMed. 36(1). 50–4. 10 indexed citations

Vade, Aruna, et al.. (2006). MRI findings of an intermuscular lipoma in a 2-year-old. Pediatric Radiology. 36(9). 974–976. 1 indexed citations

Meyer, Paul N., Hytham Al‐Masri, & Serhan Alkan. (2006). Osseous metaplasia in diffuse large B‐cell lymphoma of the kidney. American Journal of Hematology. 82(4). 321–324. 5 indexed citations

10.

Venkataraman, Girish, Fulya Öz Puyan, Keith F. Izban, et al.. (2006). Analysis of expression of heat shock protein-90 (HSP90) and the effects of HSP90 inhibitor (17-AAG) in multiple myeloma. Leukemia & lymphoma. 47(7). 1369–1378. 48 indexed citations

11.

Al‐Masri, Hytham, et al.. (2005). Megakaryoblastic leukemia with involvement of the pleural fluid. American Journal of Hematology. 79(3). 238–239. 6 indexed citations

12.

Anantharaju, Abhinandana, et al.. (2005). Posttransplantation lymphoproliferative disorder. Gastrointestinal Endoscopy. 61(2). 288–289. 2 indexed citations

13.

Al‐Masri, Hytham, et al.. (2004). The significance of the diagnosis of atypia in breast fine‐needle aspiration. Diagnostic Cytopathology. 31(5). 285–288. 23 indexed citations

14.

Paner, Gladell P., et al.. (2002). Parafallopian Tube Transitional Cell Carcinoma. Gynecologic Oncology. 86(3). 379–383. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact